- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0007341

4C Drug Safety Services LLP
About 4C Drug Safety Services LLP
Data last updated:
4C Drug Safety Services LLP is a limited liability partnership (LLP) based in Nuzvid, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Vijayawada, under LLPIN AAD-3419. Its GSTIN is 29AABFZ3734H2ZW (Karnataka). The LLP holds 3 GST registrations, of which 2 are active.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Murali Krishna Madala and Yathendra Kumar Madineni.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at H No 25 – 108 Nuzividu Municipality Siddharthanagar, Nuzvid, Andhra Pradesh, India – 521201.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹15.76 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹98.28 Lakh (net margin 6.2%) and EBITDA of ₹1.61 Cr (EBITDA margin 10.2%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 27% over five years.
The LLP has about 145 employees on its provident fund (EPFO) records.
4C Drug Safety Services LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0007341).
Company details
Recognitions & Rankings of 4C Drug Safety Services
Contact details
4C Drug Safety Services LLP's registered office is in Nuzvid, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH No 25 – 108 Nuzividu Municipality Siddharthanagar, Nuzvid, Andhra Pradesh, India – 521201
- IndustryPharma, Drug Formulation & Development
To see the full contact details of 4C Drug Safety Services LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of 4C Drug Safety Services LLP
FY 2025 filings available4C Drug Safety Services LLP reported revenue of ₹15.76 Cr (up 181% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 181% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹98.28 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 6.2% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of 4C Drug Safety Services LLP, buy the company report.
Designated partners of 4C Drug Safety Services LLP
4C Drug Safety Services has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Madala | Designated Partner | 11 Feb 2015 | 11 Years 8 Months | Current |
| Yathendra Kumar Madineni | Designated Partner | 11 Feb 2015 | 11 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving 4C Drug Safety Services LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for 4C Drug Safety Services LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
4C Drug Safety Services LLP has a workforce of 145 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.
GST
4C Drug Safety Services has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABFZ3734H2ZW | Karnataka | Active | 01 Jul 2017 |
| 36AABFZ3734H1Z2 | Telangana | Active | 15 Nov 2022 |
To see the full GST registrations and return filing status of 4C Drug Safety Services LLP, buy the company report.
Recent activity
4C Drug Safety Services LLP has 2 designated partner changes on record since 2015: 2 appointments. The latest: Murali Krishna Madala was appointed as Designated Partner on 11 Feb 2015.
Frequently asked questions
4C Drug Safety Services is an active limited liability partnership based in Nuzvid, Andhra Pradesh, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2015 (11+ years old) and is registered under LLPIN AAD-3419.
4C Drug Safety Services has 2 current designated partners:
- Murali Krishna Madala - Designated Partner
- Yathendra Kumar Madineni - Designated Partner
The latest financial statements of 4C Drug Safety Services on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of 4C Drug Safety Services is 29AABFZ3734H2ZW, registered in Karnataka. The LLP has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AABFZ3734H1Z2 (Telangana).
The LLPIN (Limited Liability Partnership Identification Number) of 4C Drug Safety Services is AAD-3419. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
4C Drug Safety Services was incorporated on 11 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Vijayawada.
Murali Krishna Madala was appointed as Designated Partner on 11 Feb 2015. Yathendra Kumar Madineni was appointed as Designated Partner on 11 Feb 2015.
Yes, 4C Drug Safety Services is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0007341).
The registered office of 4C Drug Safety Services is at H No 25 – 108 Nuzividu Municipality Siddharthanagar, Nuzvid, Andhra Pradesh, India – 521201.
4C Drug Safety Services operates in the pharma industry, in the drug formulation and development segment.

